100
Participants
Start Date
September 30, 2017
Primary Completion Date
September 30, 2018
Study Completion Date
December 31, 2018
Oral contraceptive
Daily oral contraceptive agent for 3 weeks (FLAME, containing 0.02 mg Ethinylestradiol and 0.075 mg Gestodene)
Expectant management
No intervention and a follow up visit a wewk later
Lead Sponsor
Meir Medical Center
OTHER